PMC:3220857 / 9416-9886 JSONTXT

{"target":"http://pubannotation.org/docs/sourcedb/PMC/sourceid/3220857","sourcedb":"PMC","sourceid":"3220857","source_url":"https://www.ncbi.nlm.nih.gov/pmc/3220857","text":"In line with our previous observations in 12 patients (11), a subset of the 27 patients who were included in the current study, the VLCD profoundly reduced bodyweight from 113.1 ± 3.7 to 87.7 ± 2.9 kg (P \u003c 0.05) and decreased BMI from 37.2 ± 0.9 to 28.9 ± 0.8 kg/m2 (P \u003c 0.05). In addition, in the 12 patients from whom 1H-MRS scans could be obtained, hepatic TG content reduced considerably from 21.2 ± 4.2 to 3.0 ± 0.9% (n = 12; P \u003c 0.001) as reported previously (11).","tracks":[{"project":"2_test","denotations":[{"id":"21994427-18786482-25127314","span":{"begin":55,"end":57},"obj":"18786482"},{"id":"21994427-18786482-25127315","span":{"begin":466,"end":468},"obj":"18786482"}],"attributes":[{"subj":"21994427-18786482-25127314","pred":"source","obj":"2_test"},{"subj":"21994427-18786482-25127315","pred":"source","obj":"2_test"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"2_test","color":"#e9ec93","default":true}]}]}}